The annual readjustment of medicines is valid from this Saturday (1) and should increase prices by up to 5.6%. So, it is important for the consumer to start researching to guarantee a good discount and even avoid abusive prices.
The increase projection is from the Union of Pharmaceutical Industries of the State of São Paulo (Sindusfarma). The estimate was based on the rules that establish the readjustment of drug prices, such as the Extended National Consumer Price Index (IPCA), plus productivity factors and price adjustments for each sector.
A study by the Brazilian Institute of Consumer Protection (Idec) points out that the ceiling on drug prices does not prevent abusive readjustments in purchases made by consumers in pharmacies.
This is the case, for example, of Clavulin, an antibiotic, which can reach up to 86% difference in prices. As for generic drugs, the variation was between 384% in omeprazole, a medicine for gastritis, and 91.9% in atenalol, an antihypertensive.
For the coordinator of the Idec Health Program, Ana Carolina Navarréte, the consumer should search on websites or physical stores or even participate in programs of companies that ask for the CPF to find the best values.
“Idec recommends that the consumer, first of all, research, never accept the first price he finds, he can do this on the internet, calling the pharmacy. Another thing is to evaluate the participation in programs like Popular Pharmacy, a program like this makes a lot of difference and it can give a discount of up to 90% on some medicines.”
The readjustment in medicines is made annually, from March 31, by the Chamber of Regulation of the Medicines Market (Cmed).
The increase this year will reach around 10,000 drugs available on the Brazilian market.
The annual readjustment of medicines is valid from this Saturday (1) and should increase prices by up to 5.6%. So, it is important for the consumer to start researching to guarantee a good discount and even avoid abusive prices.
The increase projection is from the Union of Pharmaceutical Industries of the State of São Paulo (Sindusfarma). The estimate was based on the rules that establish the readjustment of drug prices, such as the Extended National Consumer Price Index (IPCA), plus productivity factors and price adjustments for each sector.
A study by the Brazilian Institute of Consumer Protection (Idec) points out that the ceiling on drug prices does not prevent abusive readjustments in purchases made by consumers in pharmacies.
This is the case, for example, of Clavulin, an antibiotic, which can reach up to 86% difference in prices. As for generic drugs, the variation was between 384% in omeprazole, a medicine for gastritis, and 91.9% in atenalol, an antihypertensive.
For the coordinator of the Idec Health Program, Ana Carolina Navarréte, the consumer should search on websites or physical stores or even participate in programs of companies that ask for the CPF to find the best values.
“Idec recommends that the consumer, first of all, research, never accept the first price he finds, he can do this on the internet, calling the pharmacy. Another thing is to evaluate the participation in programs like Popular Pharmacy, a program like this makes a lot of difference and it can give a discount of up to 90% on some medicines.”
The readjustment in medicines is made annually, from March 31, by the Chamber of Regulation of the Medicines Market (Cmed).
The increase this year will reach around 10,000 drugs available on the Brazilian market.
